13F

Stock

Aclaris Therapeutics, Inc.

ACRS · held by 1 managers

Reported value

$222K

Holders

1

+0 new · −0 exited

Holders’ est. mark

−$13.1K

Price effect on 1 books still in the name

Largest holder

$222K

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC156.3K$222K−$13.1KAdded$39.9K

Positions as of Q2 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.